In Vitro Antiviral Effects of Green-Lipped Mussel Oil and Low-Molecular-Weight Fucoidan on HSV, RSV, and SARS-CoV-2 Pseudovirus
Belgheis Ebrahimi, Xu Cindy Yang, Carol Wang, Yiming Yue, Johnson Liu, Jun Lu, John A. Taylor · 2026
Read In Vitro Antiviral Effects of Green-Lipped Mussel Oil and Low-Molecular-Weight Fucoidan on HSV, RSV, and SARS-CoV-2 Pseudovirus by Belgheis Ebrahimi, Xu Cindy Yang, Carol Wang, Yiming Yue, Johnson Liu, Jun Lu, John A. Taylor (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13296062.txt.
Description
Belgheis Ebrahimi and six co-authors tested two sea-derived compounds against viruses in lab cells in 2026. One was oil from the green-lipped mussel of New Zealand. The other was a small form of fucoidan, a seaweed extract. They checked both against herpes simplex virus, RSV, and a stand-in virus carrying the SARS-CoV-2 spike.
The mussel oil showed the most promise against the coronavirus stand-in, with weaker effects on RSV and herpes. The fucoidan showed no antiviral effect on any of the three. The team measured cell harm in parallel to judge how selective each effect was. They urge follow-up work on how the oil acts and whether it works in living animals.
Catalog record
| CREATOR | Belgheis Ebrahimi, Xu Cindy Yang, Carol Wang, Yiming Yue, Johnson Liu, Jun Lu, John A. Taylor |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |